52-Week High Companies: CSX, BIIB, WY, WFMI, CVX

Author's Avatar
Mar 19, 2011
According to GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs; CSX Corp. (CSX, Financial), Biogen Indec Inc., Weyerhauser Company, Whole Foods Market Inc., and Chevron Corp.



CSX Corp. (CSX) Reached the 52-Week High of $76.22

CSX Corporation's unique combination of rail, container-shipping, intermodal and logistics services provides global reach that's second to none. CSX Corp. has a market cap of $28.23 billion; its shares were traded at around $76.22 with a P/E ratio of 18.8 and P/S ratio of 2.7. The dividend yield of CSX Corp. stocks is 1.4%. CSX Corp. had an annual average earnings growth of 16.5% over the past 10 years. GuruFocus rated CSX Corp. the business predictability rank of 2-star.

On January 24, CSX Corporation announced fourth quarter earnings of $430 million, or $1.14 per share, versus $303 million, or $0.77 per share, in the same period last year. This represents a 48 percent year-over-year improvement in earnings per share and a record fourth quarter for the company. Fourth quarter revenue grew to $2.8 billion, a 21 percent increase from the prior year, on a 13 percent increase in volume. The fourth quarter of 2010 included an extra week resulting from the company's 52/53 week fiscal reporting calendar. Excluding the extra week, revenue increased 14 percent and volume increased seven percent on a comparable basis.

Sell: EVP & CCO Clarence W Gooden sold 34,367 shares of CSX stock this month. Sell: Executive Vice President & CFO Oscar Munoz sold shares in February. Sell: Executive Vice President & COO David A Brown, Sell: SVP - Human Resources Lisa A. Mancini, and Sell: Chairman, President and CEO Michael J Ward sold shares in January.



Biogen Idec Inc. (BIIB, Financial) Reached the 52-Week High of $69.53

Biogen Indec Inc. is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. Biogen Idec Inc has a market cap of $16.75 billion; its shares were traded at around $69.53 with a P/E ratio of 13.8 and P/S ratio of 3.5. Biogen Idec Inc had an annual average earnings growth of 36.8% over the past 5 years.

On February 1, Biogen Idec Inc. announced its full year and fourth quarter 2010 results. Total revenues in 2010 were $4.7 billion, an increase of 8% versus 2009. On a reported basis, calculated in accordance with accounting principles generally accepted in the U.S. (GAAP), full-year 2010 diluted earnings per share (EPS) were $3.94, an increase of 18% over 2009. GAAP net income attributable to Biogen Idec for 2010 was $1.0 billion, an increase of 4% over 2009.

This month, Sell: Chief Acct Officer VP & Contr Robert E. Gagnon, Sell: EVP Pharmaceutical Oper & Tech John Cox, and Sell: EVP, HR, Public Affairs & Comm Craig Eric Schneier sold shares of BIIB stock. Sell: EVP, HR, Public Affairs & Comm Craig Eric Schneier sold shares in February.

Weyerhauser Company (WY, Financial) Reached the 52-Week High of $24.39

Weyerhaeuser Company is principally engaged in the growing and harvesting of timber and the manufacture, distribution and sale of forest products, real estate development and construction, and other real estate relatedactivities. Weyerhauser Company has a market cap of $13.1 billion; its shares were traded at around $24.39 with a P/E ratio of 46.7 and P/S ratio of 1.9. The dividend yield of Weyerhauser Company stocks is 2.5%.

On February 4, Weyerhaeuser Company reported net earnings of $171 million for the fourth quarter, or 32 cents per diluted share, on net sales of $1.7 billion. This compares with a net loss of $175 million on net sales of $1.5 billion for the same period last year.

Earnings for the fourth quarter of 2010 include after-tax gains of $119 million from special items. Excluding those items, the company reported net earnings of $52 million, or 10 cents per diluted share, in the fourth quarter of 2010. This compares to a net loss before special items of $109 million in the fourth quarter of 2009. For the full year 2010, Weyerhaeuser reported net earnings of $1.281 billion, or $3.99 per diluted share, on net sales of $6.6 billion. This compares with a net loss of $545 million on net sales of $5.5 billion for the full year 2009.

Sell: Senior Vice President Miles P Drake sold 10,616 shares of WY stock last week. Sell: Senior Vice President Sandy D Mcdade, Sell: Executive Vice President Thomas F Gideon, Sell: Director Nicole Weyerhaeuser Piasecki, and Sell: Senior Vice President John A Hooper sold shares in February.



Whole Foods Market Inc. (WFMI, Financial) Reached the 52-Week High of $60.44

Whole Foods Market is the largest purveyor of natural foods in the world. Whole Foods Market Inc. has a market cap of $10.49 billion; its shares were traded at around $60.44 with a P/E ratio of 37.7 and P/S ratio of 1.1. The dividend yield of Whole Foods Market Inc. stocks is 0.2%. Whole Foods Market Inc. had an annual average earnings growth of 7% over the past 10 years. GuruFocus rated Whole Foods Market Inc. the business predictability rank of 2-star.

On February 9, Whole Foods Market, Inc. reported results for the 16-week first quarter ended January 16, 2011. Sales for the quarter increased 14% to $3.0 billion. Comparable and identical store sales increased 9.1%, or 12.6% and 11.6% on a two-year stacked basis, respectively. Earnings before interest, taxes, depreciation and amortization (“EBITDA”) increased 26% from the prior year to $234.3 million, income available to common shareholders increased 79% to $88.7 million, and diluted earnings per share increased 59% to $0.51. Results included a LIFO charge of $2.0 million versus $0.2 million in the prior year; relocation, store closure and lease termination costs of $3.1 million versus $12.4 million in the prior year; and net interest income of $0.3 million versus net interest expense of $8.8 million in the prior year.

This month, Sell: Regional President Jeff Turnas, Sell: Regional President Mark T Dixon, and Sell: Director John Elstrott sold shares of WFMI stock. Sell: Regional President Joseph Rogoff, Sell: Regional President David Lannon, Sell: CEO John P Mackey, Sell: CEO Walter E Iv Robb, and Sell: EVP & CFO Glenda J Flanagan sold shares in February.

Chevron Corp. (CVX, Financial) Reached the 52-Week High of $102.8

Chevron is the fifth-largest integrated energy company in the world. Chevron Corp. has a market cap of $206.36 billion; its shares were traded at around $102.8 with a P/E ratio of 10.9 and P/S ratio of 1. The dividend yield of Chevron Corp. stocks is 2.9%. Chevron Corp. had an annual average earnings growth of 13.3% over the past 10 years. GuruFocus rated Chevron Corp. the business predictability rank of 2-star.

On January 28, Chevron Corporation reported earnings of $5.3 billion ($2.64 per share – diluted) for the fourth quarter 2010, compared with $3.1 billion ($1.53 per share – diluted) in the 2009 fourth quarter. Results in the 2010 period included gains of nearly $400 million from downstream asset sales. Foreign currency effects decreased earnings in the 2010 quarter by $99 million, compared with a decrease of $67 million a year earlier.

Last month, Sell: Executive Vice President Michael K Wirth, Sell: Executive Vice President John E Bethancourt, Sell: Vice Chairman and EVP George L Kirkland, and Sell: Vice Pres. and Comptroller Matthew J. Foehr sold shares of CVX stock. Sell: VP & CFO Patricia E Yarrington sold 42,000 shares in November.